Hematologist
CION Cancer Clinics
Why APL is treated before the diagnosis is confirmed | CION Cancer Clinics
APL treatment starts immediately because the greatest danger in the first days is serious bleeding, not the leukaemia itself. ATRA begins to settle the clotting problem quickly, while the genetic test that confirms APL can take longer. If the test does not confirm APL, ATRA is stopped. This page explains what the team is doing, the order of events, and what to ask. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why is APL treatment started before the test result?
- What changes if treatment waits for proof?
- What is the team doing in those first hours?
- What usually happens from suspicion to a confirmed plan?
- What worries families about early treatment, and what is true?
- What should you ask, and what can this page not tell you?
- Common questions about starting APL treatment early
The short answer
Why is APL treatment started before the test result?
Because in APL the biggest danger comes in the first days, and it comes from bleeding, not from the leukaemia growing. ATRA, the first medicine, starts to settle that danger quickly, while the confirming genetic test can take longer to come back.
What the doctor sees that makes them act
The suspicion usually comes from a blood report and a look at the blood under the microscope. Typical signs are low platelets, abnormal clotting tests, low fibrinogen (a clotting protein) and a particular kind of abnormal young white cell. An experienced haematologist or pathologist can often recognise this pattern the same day.
Why waiting is the riskier choice
The abnormal cells release substances that use up the body's clotting factors. Bleeding can then happen inside the brain or lungs, sometimes with little warning. Much of the serious harm in APL happens in this early window. Starting ATRA on strong suspicion shortens the time the blood is unprotected.
This is standard practice, not a shortcut
International guidance for APL recommends starting ATRA as soon as the diagnosis is suspected. Your team is not skipping a step. The confirming tests still happen, and the plan is adjusted when their results arrive. If a doctor has told you APL is likely and treatment has not started, ask directly why not. Sometimes there is a good reason, such as a transfer already arranged. Often, a clear question helps the team move faster.
Side by side
What changes if treatment waits for proof?
Waiting for the genetic test
Starting ATRA on suspicion
Clotting factors keep being used up while you wait
The clotting problem usually begins to settle within days
The bleeding risk stays at its highest
The period of highest risk is shortened
No medicine side effects, but no protection either
Side effects are possible and are watched closely
Treatment starts only once the result is back
If the test does not confirm APL, ATRA is stopped and the plan changes
Not sure whether this applies to you?
Ask an oncologistThe first-day plan
What is the team doing in those first hours?
ATRA is only one part of it. Early APL care works on several fronts at once, and the family will see all of them happening together.
Starting ATRA
A medicine taken by mouth that pushes the abnormal cells to grow up and stop releasing the substances that upset clotting. For people who cannot swallow, the team will find a way to give it.
Replacing what is used up
Platelets, plasma and cryoprecipitate may be transfused to support clotting. The amounts are decided from repeated blood tests, often more than once a day.
Watching for trouble
Nurses check for new bleeding, headache, confusion and breathing changes. Routine procedures that could cause bleeding, such as some central lines, are planned with extra care.
Sending the confirming tests
Usually includes
- Bone marrow or blood sample for PML-RARA
- A chromosome test for the t(15;17) swap
- Heart, kidney and liver checks before arsenic
The order of events
What usually happens from suspicion to a confirmed plan?
-
A blood report raises the alarm
Low platelets, abnormal clotting and unusual cells on the smear. The doctor who sees this should arrange admission the same day.
-
Admission and first medicine
ATRA is started and blood products are given. Clotting tests are repeated often. The family is told why treatment is starting now.
-
Samples go for genetic testing
A fast test for PML-RARA may be available in some laboratories. Others take longer. Either way, ATRA continues while you wait.
-
The result comes back
If APL is confirmed, arsenic trioxide is usually added, and sometimes chemotherapy. If it is not APL, ATRA is stopped and treatment for the actual diagnosis is planned.
-
The team explains the full plan
Ask for each phase in writing, the tests planned, and the signs that mean you should call the ward at once.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Did you know
APL is one of very few cancers where a medicine is routinely started on a doctor's strong suspicion alone. It is done because the medicine acts on the exact gene fault behind the disease, and because the early bleeding risk is so serious.
Commonly believed
What worries families about early treatment, and what is true?
"They are treating before they know. That is careless."
It is the opposite. The team has weighed the harm of a short course of ATRA against the harm of untreated bleeding. For suspected APL, guidance is clear that treating early is the safer choice.
"We should take him to another city first and start there."
Travel in the first days can be dangerous if clotting is badly upset. If the hospital you are in has started ATRA and can give blood products, staying put is usually safer. A second opinion can happen by sharing reports.
"If the test is negative, the medicine will have done damage."
A short course of ATRA is usually well tolerated. It can cause headache, dry skin or a reaction that the team watches for. It is stopped promptly if APL is not confirmed.
"Starting early means the bleeding risk is over."
ATRA starts to reduce the risk, but it does not remove it at once. Close monitoring in hospital continues through the early weeks.
Being straight with you
What should you ask, and what can this page not tell you?
This page cannot tell you whether your family member has APL, or how their treatment will go. It explains why the team is moving fast. The people treating them are the ones who can read the full picture.
Questions worth asking the treating team
What made you suspect APL? Which confirming test has been sent, and when will it come back? How often will clotting be checked? What signs should we tell the nurse about straight away? Who do we call at night? Writing the answers down helps when several relatives are asking.
Who this approach may not suit in the same way
Pregnancy, serious heart problems, severe liver or kidney disease and some other conditions can change which medicines are used and when. The principle of acting fast stays the same, but the details are adjusted for that person.
Where CION fits
CION's haematology team can review reports and help families understand the plan, working with hospitals that can admit APL patients. Never delay or stop treatment that has already started while you seek that view.
Questions we are asked
Common questions about starting APL treatment early
How can the doctor suspect APL without the genetic test?
APL has a recognisable pattern. Low platelets, abnormal clotting tests and low fibrinogen, together with a typical look of the abnormal cells under the microscope, point strongly towards it. The genetic test confirms what the doctor already suspects. It rarely comes as a surprise when the pattern is clear.
What if the test shows it is not APL?
ATRA is stopped, and the team plans treatment for whatever the tests do show, which is often another type of acute leukaemia. The early ATRA will not have closed any doors. The time spent protecting against bleeding was still worth it given what was suspected.
Is ATRA chemotherapy?
No. ATRA is a vitamin A based medicine that encourages the abnormal cells to grow up rather than killing them the way chemotherapy does. It does have side effects, including headache, dry skin and a reaction called differentiation syndrome, which the team checks for every day.
Why are so many blood tests being done every day?
In the early days, platelets and clotting factors can change quickly. Repeated tests tell the team how much platelet, plasma or cryoprecipitate to give and when. It can feel like a lot of needles, but each result changes a decision that protects against bleeding.
Can we take the patient home and come back for results?
This is not advised. Serious bleeding in APL can start suddenly, and the response needs blood products and doctors on hand. Early APL care belongs in hospital. Ask the team when it will be safe to think about going home, and what needs to happen first.
Should we get a second opinion before treatment starts?
Get it alongside treatment, not before. Share the blood report, smear findings and clotting results with the haematologist you want to consult. They can review the plan while ATRA continues. Pausing treatment to travel or wait for an appointment adds risk.
Is ATRA easy to get in India?
ATRA is used in India, but supply can vary between hospitals and pharmacies. Hospitals that treat APL usually keep it in stock or know where to find it quickly. If you are told it is not available, ask the team to arrange it or to transfer care safely.
Does early treatment mean the outlook is good?
Starting quickly is one of the things that helps most, and APL often responds very well. Other factors also matter, including the white count at diagnosis, bleeding before treatment, age and general health. Your haematologist can explain what this means for your family member.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- American Cancer Society — Treating Acute Promyelocytic (M3) Leukemia
- National Cancer Institute — Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version
- Leukemia & Lymphoma Society — Acute Myeloid Leukemia (AML)
- Cancer Research UK — Acute myeloid leukaemia (AML)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
APL: The Most Curable Leukaemia and the Most UrgentStart here if APL is new to youBleeding Risk in APL: What Families Must KnowThe danger early treatment is protecting againstPML-RARA: The Test That Confirms APLThe result the team is waiting forDifferentiation Syndrome: A Reaction to Watch ForThe ATRA reaction nurses check for
Talk to us
Treatment started and you have questions?
Share the reports with us. CION's haematology team will help you understand the plan without delaying care. One helpline serves every CION centre.